INTREPID POTASH INC (IPI) Stock Fundamental Analysis
NYSE:IPI - US46121Y2019 - Common Stock
28.15 USD
+0.57 (+2.07%)
28.15 USD
0 (0%)
Overall IPI gets a fundamental rating of 4 out of 10. We evaluated IPI against 84 industry peers in the Chemicals industry. IPI has a great financial health rating, but its profitability evaluates not so good. IPI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
IPI had positive earnings in the past year.
In the past year IPI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IPI reported negative net income in multiple years.
In the past 5 years IPI always reported a positive cash flow from operatings.
1.2 Ratios
IPI has a worse Return On Assets (-33.11%) than 88.10% of its industry peers.
IPI has a worse Return On Equity (-41.55%) than 77.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.66%, IPI is doing worse than 77.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.11% | ||
| ROE | -41.55% | ||
| ROIC | 0.66% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IPI has a worse Operating Margin (1.68%) than 72.62% of its industry peers.
IPI has a Gross Margin of 15.54%. This is in the lower half of the industry: IPI underperforms 73.81% of its industry peers.
In the last couple of years the Gross Margin of IPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.68% | ||
| PM (TTM) | N/A | ||
| GM | 15.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IPI is destroying value.
Compared to 1 year ago, IPI has more shares outstanding
The number of shares outstanding for IPI has been reduced compared to 5 years ago.
IPI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.28 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.28, IPI is doing good in the industry, outperforming 61.90% of the companies in the same industry.
IPI has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.05, IPI belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that IPI is not too dependend on debt financing.
IPI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. IPI outperforms 96.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.07
WACC9.06%
2.3 Liquidity
A Current Ratio of 5.28 indicates that IPI has no problem at all paying its short term obligations.
IPI has a Current ratio of 5.28. This is amongst the best in the industry. IPI outperforms 94.05% of its industry peers.
IPI has a Quick Ratio of 2.78. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
IPI's Quick ratio of 2.78 is amongst the best of the industry. IPI outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.28 | ||
| Quick Ratio | 2.78 |
3. Growth
3.1 Past
IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 151.75%, which is quite impressive.
Looking at the last year, IPI shows a quite strong growth in Revenue. The Revenue has grown by 11.91% in the last year.
Measured over the past years, IPI shows a small growth in Revenue. The Revenue has been growing by 2.96% on average per year.
EPS 1Y (TTM)151.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%850%
Revenue 1Y (TTM)11.91%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%15.18%
3.2 Future
The Earnings Per Share is expected to decrease by -4.26% on average over the next years.
Based on estimates for the next years, IPI will show a small growth in Revenue. The Revenue will grow by 0.98% on average per year.
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue Next Year3.33%
Revenue Next 2Y2.03%
Revenue Next 3Y0.98%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 47.71, the valuation of IPI can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of IPI indicates a slightly more expensive valuation: IPI is more expensive than 63.10% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IPI to the average of the S&P500 Index (26.76), we can say IPI is valued expensively.
The Forward Price/Earnings Ratio is negative for IPI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.71 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPI indicates a rather cheap valuation: IPI is cheaper than 86.90% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPI indicates a somewhat cheap valuation: IPI is cheaper than 77.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.57 | ||
| EV/EBITDA | 6.53 |
4.3 Compensation for Growth
IPI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IPI's earnings are expected to decrease with -4.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
5. Dividend
5.1 Amount
No dividends for IPI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.15
+0.57 (+2.07%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners56.05%
Inst Owner Change1.73%
Ins Owners2%
Ins Owner Change-0.05%
Market Cap374.96M
Analysts42.22
Price Target24.48 (-13.04%)
Short Float %2.44%
Short Ratio1.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)598.3%
Min EPS beat(2)324.33%
Max EPS beat(2)872.28%
EPS beat(4)2
Avg EPS beat(4)261.99%
Min EPS beat(4)-142.02%
Max EPS beat(4)872.28%
EPS beat(8)2
Avg EPS beat(8)-89.19%
EPS beat(12)2
Avg EPS beat(12)-70.18%
EPS beat(16)3
Avg EPS beat(16)-55.32%
Revenue beat(2)2
Avg Revenue beat(2)21.74%
Min Revenue beat(2)17.42%
Max Revenue beat(2)26.05%
Revenue beat(4)4
Avg Revenue beat(4)20.54%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)22.42%
Revenue beat(12)11
Avg Revenue beat(12)21.59%
Revenue beat(16)15
Avg Revenue beat(16)18.93%
PT rev (1m)14.29%
PT rev (3m)26.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)46.88%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.71 | ||
| Fwd PE | N/A | ||
| P/S | 1.33 | ||
| P/FCF | 14.57 | ||
| P/OCF | 6.93 | ||
| P/B | 0.77 | ||
| P/tB | 0.81 | ||
| EV/EBITDA | 6.53 |
EPS(TTM)0.59
EY2.1%
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)1.93
FCFY6.86%
OCF(TTM)4.06
OCFY14.42%
SpS21.22
BVpS36.32
TBVpS34.88
PEG (NY)0.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.11% | ||
| ROE | -41.55% | ||
| ROCE | 0.84% | ||
| ROIC | 0.66% | ||
| ROICexc | 0.78% | ||
| ROICexgc | 0.81% | ||
| OM | 1.68% | ||
| PM (TTM) | N/A | ||
| GM | 15.54% | ||
| FCFM | 9.11% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 71.13% | ||
| Cap/Sales | 10.03% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 121.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.28 | ||
| Quick Ratio | 2.78 | ||
| Altman-Z | 2.28 |
F-Score4
WACC9.06%
ROIC/WACC0.07
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)151.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%850%
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue 1Y (TTM)11.91%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%15.18%
Revenue Next Year3.33%
Revenue Next 2Y2.03%
Revenue Next 3Y0.98%
Revenue Next 5YN/A
EBIT growth 1Y129.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1675.2%
EBIT Next 3Y142.16%
EBIT Next 5YN/A
FCF growth 1Y159.44%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y21.52%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%